Form 4: Health In Tech CEO Granted 80,000 Restricted Shares

Health In Tech's CEO, Tim Donald Johnson, was granted 80,000 restricted Class A Common Stock shares, aligning his incentives with a new company initiative.

Summary

• Tim Donald Johnson, Chief Executive Officer, Director, and 10% Owner of Health In Tech, Inc. (HIT), was granted 80,000 shares of Class A Common Stock.
• The transaction occurred on September 24, 2025, with a transaction price of $0 per share, indicating a grant of restricted stock.
• These shares were granted pursuant to the Health in Tech Equity Incentive Plan.
• The vesting schedule for the 80,000 restricted shares is tied to the progression of a new company 'Initiative': one-third vests monthly over 12 months starting from the signing of a letter of intent or memorandum of understanding, one-third vests monthly over 12 months starting from the proof-of-concept or beta launch, and the final one-third vests monthly over 12 months starting from the full commercial launch of the Initiative.
• Following this transaction, Tim Donald Johnson beneficially owns 22,549,741 shares of Class A Common Stock directly, which includes 137,495 previously held restricted shares and 22,412,246 unrestricted Class A Common Stock shares.
• This beneficial ownership excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase Class A Common Stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to the CEO is a positive signal for management alignment and commitment to a new company initiative. While not a direct cash investment, it incentivizes long-term performance and shareholder value creation. The vesting conditions, however, introduce a degree of uncertainty.

Positives

• The grant of restricted stock to the CEO aligns management's long-term interests with the company's performance and the success of a new strategic initiative.
• The equity incentive plan encourages the CEO to drive the development and commercialization of the 'Initiative', potentially creating significant shareholder value.

Negatives

• The shares were granted at a price of $0, meaning no direct cash investment was made by the CEO for these specific shares at the time of grant.
• The vesting of the restricted shares is contingent on the successful achievement of future milestones for a new 'Initiative', introducing uncertainty regarding the ultimate realization of the incentive.

Risks

• Execution risk associated with the new 'Initiative' being developed by the company; failure to meet milestones (LOI/MOU, proof-of-concept/beta launch, full commercial launch) could prevent vesting of the restricted shares.
• Market risk affecting the value of the Class A Common Stock, which would impact the ultimate value of the vested shares.

Future Outlook

The company's future outlook is implicitly tied to the successful development and launch of a new 'Initiative', with key milestones including the signing of a letter of intent or memorandum of understanding, entry into proof-of-concept or beta launch, and full commercial launch, which will trigger the vesting of the CEO's restricted stock.

Management Comments

• The grant of restricted stock to the CEO is intended to incentivize his commitment to the successful development and launch of a new company initiative, aligning his interests with long-term shareholder value creation.

Industry Context

Equity grants, particularly restricted stock, are a common and widely accepted practice in executive compensation across various industries. They serve to align the interests of key management personnel with the long-term strategic goals and financial performance of the company, especially when tied to specific project milestones or overall company growth.

Comparison to Industry Standards

• The use of restricted stock grants tied to performance milestones is a standard executive compensation mechanism, comparable to practices seen in technology and growth-oriented companies aiming to incentivize innovation and project execution.
• While specific comparable companies or projects are not detailed in the filing, this type of incentive structure is frequently employed by firms seeking to motivate leadership in developing new products or market entries.

Corporate Governance

Related Party Transactions

• The grant of 80,000 restricted shares of Class A Common Stock to Tim Donald Johnson, the Chief Executive Officer, Director, and 10% Owner, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the CEO's interests with long-term company performance and the success of a new strategic initiative.
• Employees: The success of the 'Initiative' could lead to growth opportunities and stability within the company.

Next Steps

• The company will proceed with the development of its new 'Initiative', aiming to achieve key milestones such as signing a letter of intent or memorandum of understanding, entering proof-of-concept or beta launch, and achieving full commercial launch, which are critical for the vesting of the CEO's restricted shares.

Key Dates

Recommendation

The grant of restricted stock to the CEO is a positive indicator of management's commitment and alignment with the company's strategic direction, particularly a new initiative. This generally supports long-term shareholder value. However, as it's a grant rather than a direct cash purchase by the CEO, and the vesting is tied to future, unproven milestones, it doesn't present an immediate 'buy' signal for external investors. It reinforces a 'hold' position for those already invested, awaiting further developments on the 'Initiative'.

Keywords

Health In Tech, HIT, Tim Johnson, CEO, restricted stock, equity incentive plan, Form 4, insider transaction, beneficial ownership, corporate governance, executive compensation